Cargando…

The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease.

Detalles Bibliográficos
Autores principales:	Habib, N. A., Hershman, M. J., Haberland, F., Papp, L., Wood, C. B., Williamson, R. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1986
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001389/ https://www.ncbi.nlm.nih.gov/pubmed/3459510

Ejemplares similares

Clinical Evaluation of Tumour Marker Combinations in the Differential Diagnosis of Benign and Malignant Liver Disease
por: Lucarotti, M. E., et al.
Publicado: (1991)

Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
por: Haglund, C., et al.
Publicado: (1989)

Proceedings: Radioimmunoassay of casein in the serum of normal subjects and of patients with various malignancies.
por: Hendrick, J. C., et al.
Publicado: (1974)

Methods of hormone radioimmunoassay

New Techniques in Tumour Localization and Radioimmunoassay
por: Beardwell, C. G.
Publicado: (1975)

Computerized quality control of radioimmunoassay in Korea.
por: Chung, J. K., et al.
Publicado: (1988)

A radioimmunoassay for cytosine arabinoside.
por: Piall, E. M., et al.
Publicado: (1979)

Radioimmunoassay of bleomycin in plasma and urine.
por: Teale, J. D., et al.
Publicado: (1977)

Enzyme-linked PNA lectin binding assay compared with CA19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer.
por: Ching, C. K., et al.
Publicado: (1989)

Development and application of a radioimmunoassay for methotrexate.
por: Aherne, G. W., et al.
Publicado: (1977)

Radioimmunoassay of Parathyroid Hormone in Primary Hyperparathyroidism
por: Buckle, R. M.
Publicado: (1968)

Effect of Radioimmunoassay on Accuracy of Thyroid Hormone Detection
por: Wu, Zhixiang
Publicado: (2022)

Double antibody radioimmunoassay for monitoring metastatic breast cancer.
por: Schecter, R. L., et al.
Publicado: (1988)

Localization by immunoperoxidase and estimation by radioimmunoassay of carcinoembryonic antigen in colonic polyps.
por: Sharkey, R. M., et al.
Publicado: (1977)

Proceedings: Radioimmunoassay of HCG, alpha and beta subunits in cancer.
por: Franchimont, P., et al.
Publicado: (1974)

Quantification of Rat Kisspeptin Using a Novel Radioimmunoassay
por: Kinsey-Jones, James S., et al.
Publicado: (2014)

Differentiating benign from malignant pancreatic cysts on computed tomography
por: Yadav, Rajesh Kumar, et al.
Publicado: (2020)

Differentiation of malignant from benign pancreatic mass by Tl-201 abdominal SPECT.
por: Bom, H. S., et al.
Publicado: (1995)

Correction: Quantification of Rat Kisspeptin Using a Novel Radioimmunoassay
Publicado: (2014)

A sensitive radioimmunoassay for the determination of antibodies to mouse hepatitis virus
por: Leibowitz, J.L., et al.
Publicado: (1983)

Anti-Thyroxine Antibodies in Autoimmune Thyroiditis(*): Effect on radioimmunoassay and binding characteristics
por: Cho, Bo Youn, et al.
Publicado: (1986)

An improved antigenic marker of human lung carcinomas and its use in radioimmunoassays.
por: Wolf, A., et al.
Publicado: (1981)

Application of monoclonal antibodies to purified CEA in clinical radioimmunoassay of human serum.
por: Rogers, G. T., et al.
Publicado: (1981)

RADIOIMMUNOASSAY OF SERUM ALBUMIN PRODUCED BY HUMAN EMBRYONIC LIVER IN MONOLAYER CULTURE
por: Bissell, D. Montgomery, et al.
Publicado: (1972)

Comparison of VIDAS and Radioimmunoassay Methods for Measurement of Cortisol Concentration in Bovine Serum
por: Proverbio, Daniela, et al.
Publicado: (2013)

Histomorphometric and radioimmunoassay studies of the rat endometrium following peanut oil treatment
por: Tchokonte-Nana, Venant, et al.
Publicado: (2011)

Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.
por: Cooper, E. H., et al.
Publicado: (1985)

Pancreatic cyst fluid analysis for differential diagnosis between benign and malignant lesions
por: TALAR-WOJNAROWSKA, RENATA, et al.
Publicado: (2013)

Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses
por: Terlikowska, Katarzyna M., et al.
Publicado: (2016)

Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers
por: Yue, Tingting, et al.
Publicado: (2011)

An immunoradiometric assay of tumour-antigen 4 (TA-4): a comparison with conventional radioimmunoassay.
por: Mino-Miyagawa, N., et al.
Publicado: (1990)

Management of Benign and Malignant Pancreatic Duct Strictures
por: Dawod, Enad, et al.
Publicado: (2018)

Comparison of progesterone assay by chemiluminescence or radioimmunoassay for clinical decision-making in canine reproduction
por: Nöthling, Johan O., et al.
Publicado: (2019)

Cancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma Marker
por: North, William G
Publicado: (2023)

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
por: Haglund, C., et al.
Publicado: (1994)

Detection of Ca antigen in sera from normal individuals and patients with benign and malignant breast disease.
por: Goodall, A. B., et al.
Publicado: (1985)

Topiramate Treatment May Interfere With Urinary Cortisol Measurement By Radioimmunoassay (RIA) – A Case Report
por: Chan, Pak Cheung R., et al.
Publicado: (2005)

Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant
por: Liu, Wei, et al.
Publicado: (2018)

Prevalence of Autoimmune Pancreatitis and Other Benign Disorders in Pancreatoduodenectomy for Presumed Malignancy of the Pancreatic Head
por: van Heerde, M. J., et al.
Publicado: (2012)

Evaluation of assays for thyroxine, triodotyronine and thyroid-stimulating hormone on the ARIA II automated radioimmunoassay instrument
por: Duffy, M. J., et al.
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_ef74lcc59q0ugquriu5edia1va